Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CML. (Q39236262)
Jump to navigation
Jump to search
scientific article published on 27 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CML. |
scientific article published on 27 May 2010 |
Statements
1 reference
Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib-resistant CML. (English)
1 reference
1 reference
E Weisberg
1 reference
X Deng
1 reference
H G Choi
1 reference
R Barrett
1 reference
S Adamia
1 reference
A Ray
1 reference
D Moreno
1 reference
N Gray
1 reference
J D Griffin
1 reference
27 May 2010
1 reference
1 reference
24
1 reference
7
1 reference
1375-1378
1 reference
Identifiers
1 reference
1 reference
1 reference